HIV-1 suppression by early treatment with hydroxyurea, didanosine, and a protease inhibitor

被引：44
|
作者：
Lisziewicz, J
Jessen, H
Finzi, D
Siliciano, RF
Lori, F [1 ]
机构：
[1] Georgetown Univ, RIGHT, Washington, DC 20007 USA
[2] Policlin San Matteo, IRCCS, RIGHT, I-27100 Pavia, Italy
[3] Jessen Praxis, Berlin, Germany
[4] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA
来源：
LANCET | 1998年 / 352卷 / 9123期
关键词：
D O I：
10.1016/S0140-6736(98)24029-3
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：199 / 200
页数：2
相关论文
共 50 条
  • [41] Hydroxyurea in the treatment of HIV-1 infection: toxicity and side effects
    Maserati, R
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 1999, 13 (03): : 181 - 185
  • [42] Abacavir, efavirenz, didanosine, with or without hydroxyurea, in HIV-infected adults failing initial nucleoside/protease inhibitor-containing regimens
    Susan Swindells
    Calvin J Cohen
    Daniel S Berger
    Karen T Tashima
    Qiming Liao
    Bonnie F Pobiner
    Jerry W Snidow
    Gary E Pakes
    Jaime E Hernandez
    BMC Infectious Diseases, 5
  • [43] Abacavir, efavirenz, didanosine, with or without hydroxyurea, in HIV-infected adults failing initial nucleoside/protease inhibitor-containing regimens
    Swindells, S
    Cohen, CJ
    Berger, DS
    Tashima, KT
    Liao, QM
    Pobiner, BF
    Snidow, JW
    Pakes, GE
    Hernandez, JE
    BMC INFECTIOUS DISEASES, 2005, 5 (1)
  • [44] Targeting structural flexibility in HIV-1 protease inhibitor binding
    Hornak, Victor
    Simmerling, Carlos
    DRUG DISCOVERY TODAY, 2007, 12 (3-4) : 132 - 138
  • [45] Prediction of HIV-1 Protease/Inhibitor Affinity using RosettaLigand
    Lemmon, Gordon
    Kaufmann, Kristian
    Meiler, Jens
    CHEMICAL BIOLOGY & DRUG DESIGN, 2012, 79 (06) : 888 - 896
  • [46] Antimalarial activity of HIV-1 protease inhibitor in chromone series
    Lerdsirisuk, Pradith
    Maicheen, Chirattikan
    Ungwitayatorn, Jiraporn
    BIOORGANIC CHEMISTRY, 2014, 57 : 142 - 147
  • [47] Molecular dynamical analysis of POSS as an HIV-1 protease inhibitor
    Springsted, Greg
    Parish, Carol A.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 238
  • [48] Turn-On Assay for HIV-1 Protease Inhibitor Selection
    Shi, Yan
    Li, Zhuang
    Wang, Hongda
    ACS APPLIED BIO MATERIALS, 2020, 3 (11) : 7706 - 7711
  • [49] Crystal structure of a novel synthetic inhibitor of HIV-1 protease
    Hilgeroth, A
    Tykarska, E
    Jaskolski, M
    JOURNAL OF MOLECULAR STRUCTURE, 2002, 605 (01) : 63 - 70
  • [50] Novel heterocyclic analogues of the HIV-1 protease inhibitor, Ritonavir
    Kaye, PT
    Musa, MA
    Nchinda, AT
    Nocanda, XW
    SYNTHETIC COMMUNICATIONS, 2004, 34 (14) : 2575 - 2589
12345